BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 23651616)

  • 21. Rapamycin as a Potential Alternative Drug for Squamous Cell Gingiva Carcinoma (Ca9-22): A Focus on Cell Cycle, Apoptosis and Autophagy Genetic Profile.
    Papadakos S; Issa H; Alamri A; Alamri A; Semlali A
    Pharmaceuticals (Basel); 2024 Jan; 17(1):. PubMed ID: 38276004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiproliferative activities through accelerating autophagic flux by basidalin and its analogs in human cancer cells.
    Matagawa T; Sasazawa Y; Agui K; Fujimaki M; Kawano S; Ogura A; Takao KI; Igarashi M; Simizu S
    Bioorg Med Chem Lett; 2024 May; 104():129713. PubMed ID: 38522588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autophagy inhibition improves the cytotoxic effects of receptor tyrosine kinase inhibitors.
    Aveic S; Pantile M; Polo P; Sidarovich V; De Mariano M; Quattrone A; Longo L; Tonini GP
    Cancer Cell Int; 2018; 18():63. PubMed ID: 29713246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crosstalk between m6A modification and autophagy in cancer.
    Chen T; Zheng L; Luo P; Zou J; Li W; Chen Q; Zou J; Qian B
    Cell Biosci; 2024 Apr; 14(1):44. PubMed ID: 38576024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The MicroRNA-Based Strategies to Combat Cancer Chemoresistance
    Lei Y; Chen L; Liu J; Zhong Y; Deng L
    Front Oncol; 2022; 12():841625. PubMed ID: 35211417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Research Progress and Prospects of Autophagy in the Mechanism of Multidrug Resistance in Tumors.
    Long W; Zhang L; Wang Y; Xie H; Wang L; Yu H
    J Oncol; 2022; 2022():7032614. PubMed ID: 35136409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploiting DNA Damage Repair in Precision Cancer Therapy: BRCA1 as a Prime Therapeutic Target.
    Raimundo L; Calheiros J; Saraiva L
    Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contrast effects of autophagy in the treatment of bladder cancer.
    Konac E; Kurman Y; Baltaci S
    Exp Biol Med (Maywood); 2021 Feb; 246(3):354-367. PubMed ID: 32954815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cucurbitacin B and cisplatin induce the cell death pathways in MB49 mouse bladder cancer model.
    Kurman Y; Kiliccioglu I; Dikmen AU; Esendagli G; Bilen CY; Sozen S; Konac E
    Exp Biol Med (Maywood); 2020 May; 245(9):805-814. PubMed ID: 32252554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of long non-coding RNAs in mediating chemoresistance by modulating autophagy in cancer.
    Jin KT; Lu ZB; Lv JQ; Zhang JG
    RNA Biol; 2020 Dec; 17(12):1727-1740. PubMed ID: 32129701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Androgen receptor antagonist bicalutamide induces autophagy and apoptosis via ULK2 upregulation in human bladder cancer cells.
    Hao K; Zhao S; Cui D; Zhang Y; Jiang C; Jing Y; Xia S; Han B
    Int J Clin Exp Pathol; 2017; 10(7):7603-7615. PubMed ID: 31966605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The combination of NVP-BEZ235 and rapamycin regulates nasopharyngeal carcinoma cell viability and apoptosis via the PI3K/AKT/mTOR pathway.
    Luo H; Yu YY; Chen HM; Wu W; Li Y; Lin H
    Exp Ther Med; 2019 Jan; 17(1):99-106. PubMed ID: 30651769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NVP-BEZ235 synergizes cisplatin sensitivity in osteosarcoma.
    Huang JC; Cui ZF; Chen SM; Yang LJ; Lian HK; Liu B; Su ZH; Liu JS; Wang M; Hu ZB; Ouyang JY; Li QC; Lu H
    Oncotarget; 2018 Feb; 9(12):10483-10496. PubMed ID: 29535821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of 7-(4'-Cyanophenyl)indoline-1-benzenesulfonamide as a mitotic inhibitor to induce apoptotic cell death and inhibit autophagy in human colorectal cancer cells.
    Wu TY; Cho TY; Lu CK; Liou JP; Chen MC
    Sci Rep; 2017 Sep; 7(1):12406. PubMed ID: 28963527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autophagy and multidrug resistance in cancer.
    Li YJ; Lei YH; Yao N; Wang CR; Hu N; Ye WC; Zhang DM; Chen ZS
    Chin J Cancer; 2017 Jun; 36(1):52. PubMed ID: 28646911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MEK inhibitors cobimetinib and trametinib, regressed a gemcitabine-resistant pancreatic-cancer patient-derived orthotopic xenograft (PDOX).
    Kawaguchi K; Igarashi K; Murakami T; Kiyuna T; Lwin TM; Hwang HK; Delong JC; Clary BM; Bouvet M; Unno M; Hoffman RM
    Oncotarget; 2017 Jul; 8(29):47490-47496. PubMed ID: 28537897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autophagy and urothelial carcinoma of the bladder: A review.
    Chandrasekar T; Evans CP
    Investig Clin Urol; 2016 Jun; 57 Suppl 1(Suppl 1):S89-97. PubMed ID: 27326411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blockage of Autophagy Rescues the Dual PI3K/mTOR Inhibitor BEZ235-induced Growth Inhibition of Colorectal Cancer Cells.
    Oh I; Cho H; Lee Y; Cheon M; Park D; Lee Y
    Dev Reprod; 2016 Mar; 20(1):1-10. PubMed ID: 27294206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PI3K/AKT/mTOR and sonic hedgehog pathways cooperate together to inhibit human pancreatic cancer stem cell characteristics and tumor growth.
    Sharma N; Nanta R; Sharma J; Gunewardena S; Singh KP; Shankar S; Srivastava RK
    Oncotarget; 2015 Oct; 6(31):32039-60. PubMed ID: 26451606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autophagy Correlates with the Therapeutic Responsiveness of Malignant Pleural Mesothelioma in 3D Models.
    Barbone D; Follo C; Echeverry N; Gerbaudo VH; Klabatsa A; Bueno R; Felley-Bosco E; Broaddus VC
    PLoS One; 2015; 10(8):e0134825. PubMed ID: 26284517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.